Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | DUSP3 | P51452 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | DGKA | P23743 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | FAAH | O00519 | 2/20 | 0.68 |
| ▸ | PRKCA | P17252 | 3/20 | 0.66 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.66 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.66 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.66 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.65 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.65 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.65 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.65 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.65 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.65 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119138 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Monoctanoin Component B SCHEMBL22366087 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2508008 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685815 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL21685794 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL4488 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL2489632 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glyceryl Monostearate SCHEMBL1653474 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glycerol Monopalmitate SCHEMBL977143 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL10937708 | 1.00 | LMNA (1.00) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100859-A1 | COSMETIC COMPOSITION FOR IMPROVING PHOTOAGING AND THERMAL AGING, AND MANUFACTURING METHOD THEREFOR | 서린컴퍼니(주) | 2026-05-15 | — | — | WO | claimed |
| US-20260014293-A1 | HEMOSTATIC AGENT IN PASTE FORM, USE THEREOF, AND METHOD FOR PRODUCING A LOCAL ACTIVE AGENT RELEASE SYSTEM | HERAEUS MEDICAL GMBH (DE) | 2026-01-15 | — | — | US | claimed |
| EP-4661853-A1 | LIPID NANOPARTICLES FOR THE TREATMENT OF OCULAR DISEASES | Universitat de Barcelona (ES) | 2025-12-17 | — | — | EP | claimed |
| US-12419822-B2 | Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same | TOTALENERGIES ONETECH (FR) | 2025-09-23 | — | — | US | claimed |
| US-20250241899-A1 | Topical Antifungal Non-Aqueous Formulations and Preparation Methods Thereof | Hefei Cosource Pharmaceuticals Co., Ltd (CN) | 2025-07-31 | — | — | US | claimed |
| EP-4529477-A1 | POROUS EXPANDING BIOCOMPATIBLE SCAFFOLDS | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | claimed |
| EP-4529468-A1 | FORMULATION OF API'S AND EXCIPIENT'S IN AN ICELL VIA HYDROPHOBIC ION PAIRING | Danmarks Tekniske Universitet (DK) | 2025-04-02 | — | — | EP | claimed |
| US-20240301138-A1 | POLMERIC TRANSFECTION REAGENTS TO DELIVER NUCLEIC ACIDS FOR HOST CELL MODIFICATION | RJH BIOSCIENCES INC. (CA) | 2024-09-12 | — | — | US | claimed |
| WO-2024165565-A1 | LIPID NANOPARTICLES FOR THE TREATMENT OF OCULAR DISEASES | UNIVERSITAT DE BARCELONA (ES) | 2024-08-15 | — | — | WO | claimed |
| EP-4410281-A1 | LIPID NANOPARTICLES FOR THE TREATMENT OF OCULAR DISEASES | Universitat de Barcelona (ES) | 2024-08-07 | — | — | EP | claimed |
| EP-3254709-B1 | TWO COMPONENT POLYMETHACRYLATE BONE CEMENT IN PASTE FORM | HERAEUS MEDICAL GMBH (DE) | 2020-02-26 | — | — | EP | claimed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | claimed |
| US-20170348457-A1 | PASTY TWO-COMPONENT POLYMETHACRYLATE BONE CEMENT | HERAEUS MEDICAL GMBH (DE) | 2017-12-07 | — | — | US | claimed |
| EP-2730296-B1 | Polymethyl methacrylate bone cement | HERAEUS MEDICAL GMBH (DE) | 2017-01-11 | — | — | EP | claimed |
| US-20160095876-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | CRG SERVICING LLC | 2016-04-07 | — | — | US | claimed |
| US-9233188-B2 | Polymethylmethacrylate bone cement | HERAEUS MEDICAL GMBH (DE) | 2016-01-12 | — | — | US | claimed |
| US-8829053-B2 | Biocidal compositions and methods of using the same | ROCHAL INDUSTRIES LLP (US) | 2014-09-09 | — | — | US | claimed |
| US-20140135418-A1 | POLYMETHYLMETHACRYLATE BONE CEMENT | HERAEUS MEDICAL GMBH (DE) | 2014-05-15 | — | — | US | claimed |
| EP-2730296-A2 | Polymethyl methacrylate bone cement | Heraeus Medical GmbH (DE) | 2014-05-14 | — | — | EP | claimed |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLP (US) | 2013-06-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160095876-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | CUTA, MMP8, MMP1 | LMNA 1246/4885KDM4E 4848/4885DUSP3 1258/4885 |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | LMNA 1237/4885KDM4E 4848/4885DUSP3 1252/4885 |
| US-20260014293-A1 | HEMOSTATIC AGENT IN PASTE FORM, USE THEREOF, AND METHOD FOR PRODUCING A LOCAL ACTIVE AGENT RELEASE SYSTEM | F9, PLAT, F12 | LMNA 891/4885KDM4E 1733/4885DUSP3 2110/4885 |
| US-20240301138-A1 | POLMERIC TRANSFECTION REAGENTS TO DELIVER NUCLEIC ACIDS FOR HOST CELL MODIFICATION | POLRMT, POLM, PLTP | LMNA 258/4885KDM4E 3691/4885DUSP3 4301/4885 |
| US-12419822-B2 | Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same | ACOX3, ELOVL3, ACOX1 | LMNA 333/4885KDM4E 1588/4885DUSP3 4697/4885 |
| US-20130150451-A1 | BIOCIDAL COMPOSITIONS AND METHODS OF USING THE SAME | GCG, BID, DGAT1 | LMNA 4213/4885KDM4E 3836/4885DUSP3 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.